US2006172982A1PendingUtilityA1

Formulation comprising tetracycline or derivative and method of treating or preventing infections and inflammatory conditions

Individually held — no corporate assignee on recordPriority: Jan 28, 2005Filed: Jan 28, 2005Published: Aug 3, 2006
Est. expiryJan 28, 2025(expired)· nominal 20-yr term from priority
Inventors:Wallace Gardner
A61K 31/65A61K 9/0043A61K 47/10A61K 9/06A61K 9/0014
35
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Therapeutic composition and method for treating or preventing various conditions and diseases, including inflammatory conditions, allergies, particularly seasonal allergies, and the common cold. In a preferred embodiment, the therapeutic composition is a formulation comprising an antibiotic, preferably a tetracycline, most preferably doxycycline, which has not been chemically modified to eliminate antimicrobial efficacy. The antibiotic is preferably in a vehicle to form a salve or paste for topical application to the skin or the nasal cavity. The therapeutic composition most preferably is a self-applied formulation that consists essentially of a tetracycline, most preferably doxycycline, which has not been chemically modified to eliminate antimicrobial efficacy, and a vehicle such as boric acid, zinc oxide or petroleum jelly.

Claims

exact text as granted — not AI-modified
1 . A therapeutic composition having anti-inflammatory activity comprising an amount of a tetracycline effective for treating an inflammatory condition, said tetracycline being dispersed in a salve selected from the group consisting of petroleum jelly, zinc oxide and boric acid, said therapeutic composition being in topical delivery form and adapted for self-administration.  
   
   
       2 . The therapeutic composition of  claim 1 , wherein said tetracycline has not been chemically modified to eliminate antimicrobial efficacy.  
   
   
       3 . The therapeutic composition of  claim 1 , wherein said therapeutic composition is devoid of a morpholinoamino alcohol or pharmaceutically acceptable salt thereof.  
   
   
       4 . The composition of  claim 1 , wherein said tetracycline is doxycycline.  
   
   
       5 . The composition of  claim 1 , wherein said anti-inflammatory activity is anti-psoriatic activity.  
   
   
       6 . A method of treating or preventing psoriasis in a patient comprising topically applying to the skin of said patient affected with psoriasis the therapeutic composition of  claim 1 .  
   
   
       7 . The method of  claim 9 , further comprising covering said applied composition.  
   
   
       8 . The method of  claim 10 , wherein said tetracycline is doxycycline.  
   
   
       9 . A kit, comprising a tetracycline, a salve as a carrier for said tetracycline, and instructions for use of said tetracycline and carrier for treating symptoms of the common cold or allergies.  
   
   
       10 . The kit of  claim 12  wherein said tetracycline is doxycycline.  
   
   
       11 . The kit of  claim 12 , wherein said instructions for use require application of said salve to the nasal cavity.  
   
   
       12 . A method of relieving symptoms in a patient due to the common cold or allergies, comprising directly applying to the nasal passages of said patient an effective amount of a salve comprising tetracycline dispersed in a carrier selected from the group consisting of petroleum jelly, boric acid and zinc oxide.  
   
   
       13 . The method of  claim 12  wherein said tetracycline is doxycycline.  
   
   
       14 . The method of  claim 12 , further comprising blowing the nose of said patient to expel excess salve.

Join the waitlist — get patent alerts

Track US2006172982A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.